The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 1, 2010, Pages 263-269

  Chiocchetti, A ^a   Orilieri, E ^a   Cappellano, G ^a   Barizzone, N ^a   D'Alfonso, S ^a   D'Annunzio, G ^b   Lorini, R ^b   Ravazzolo, R ^b   Cadario, F ^a   Martinetti, M ^c   Calcaterra, V ^d   Cerutti, F ^e   Bruno, G ^f   Larizza, D ^d   Dianzani, Umberto ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

Genetic susceptibility; Osteopontin; Single nucleotide polymorphism; Type 1 diabetes mellitus

Indexed keywords

HLA DQ1 ANTIGEN; HLA DQB1 ANTIGEN; OSTEOPONTIN;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77951755280     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300124     Document Type: Article

References (23)

1. Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther 2005; 12:580-591
2. Santamaria P. Effector lymphocytes in autoimmunity. Curr Opin Immunol 2001; 13:663-669
3. Hirschhorn JN. Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 2003; 4:87-100.
4. Jahromi MM, Eisenbarth GS. Genetic determinants of type 1 diabetes across populations. Ann NY Acad Sci 2006; 1079:289-299.
5. Buzzetti R, Galgani A, Petrone A, et al. Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev 2004; 20:137-143
6. Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes 1999; 48:1353-1358
7. Marre M. Genetics and the prediction of complications in type 1 diabetes. Diabetes Care 1999; 2:B53-58.
8. Todd JA. Genetics of type 1 diabetes. Pathol Biol 1997; 45:219-227
9. Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest 2003; 112:147-9.
10. O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000; 81:373-390
11. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 2000; 21:475-478
12. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107:1055-1061
13. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287:860-864
14. Chiocchetti A, Indelicato M, Bensi T, et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 2004; 103:1376-1382
15. Chiocchetti A, Comi C, Indelicato M, et al. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J Neuroimmunol 2005; 163:172-178
16. D'Alfonso S, Barizzone N, Giordano M, et al. Two single-nucleotide polymorphisms in the 5prime; and 3prime; ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2005; 52:539-547
17. Marciano R, D'Annunzio G, Minuto N, Pasquali L, Santamaria A, Di Duca M, Ravazzolo R, Lorini R. Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients. Clin Immunol 2009; 131:84-91.
18. Iafusco D, Stazi MA, Cotichini R, et al. Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Permanent diabetes mellitus in the first year of life. Diabetologia 2002; 45:798-804.
19. Lipton RB, Kocova M, LaPorte RE, Dorman JS, Orchard TJ, Riley WJ, Drash AL, Becker DJ, Trucco M. Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol 1992; 136:503-512
20. Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008; 40:1399-1401
21. Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448:591-594
22. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9:356-369
23. Cavalli-Sforza L, Menozzi P, Piazza. A. The history and geography of human genes. Princeton University press (Princeton, New Jersey) 1994; p. 255-299